About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
News
All categories
Portfolio
Portfolio
Genetico
Nextgen
Gemabank
Biotechnology Developments
Reprobank
Vitacel
09.06.2023
News
Russia’s genetic embryo testing market valued at $13.05 million
25.04.2023
News
Nature on an innovative treatment developed by the Human Stem Cell Institute
25.04.2023
News
Moscow Exchange listed Genetico shares in the IIM sector
21.04.2023
News
Moscow Exchange begins trading in futures and options on HSCI shares
19.04.2023
News
Children born from three parents will be rid of genetic diseases
19.04.2023
News
Moscow Exchange published the application procedure for Genetico’s IPO
10.04.2023
News
RBT investors received an offer
1
2
3
4
5
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information